Form 8-K - Current report:
SEC Accession No. 0001193125-17-363405
Filing Date
2017-12-07
Accepted
2017-12-07 08:49:03
Documents
4
Period of Report
2017-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d469653d8k.htm 8-K 21089
2 EX-1.1 d469653dex11.htm EX-1.1 170097
3 EX-5.1 d469653dex51.htm EX-5.1 7937
4 GRAPHIC g469653g1207102915993.jpg GRAPHIC 2524
  Complete submission text file 0001193125-17-363405.txt   203848
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 171243591
SIC: 2834 Pharmaceutical Preparations